Recommendations for Titration and Administration of Oral Semaglutide for the Treatment of Type 2 Diabetes during Ramadan
Background: Injectable glucagon-like peptide-1 receptor agonists (GLP-1RAs) are proven to be well tolerated and efficacious in people with type 2 diabetes mellitus (T2DM) fasting during Ramadan. The first oral GLP-1RA semaglutide, also indicated for the treatment of T2DM, has specific dosing instruc...
Main Authors: | Mohamed Hassanein, Abdulqawi Almansari, Ebtesam Ba-Essa, Fatheya F. Alawadi, Hussein ElBadawi, Rakesh Kumar Sahay, Rayaz Malik, Rohana Abdul Ghani, Salah Abusnana, Shehla Shaikh, Sueziani Binte Zainudin, Tarik Elhadd, Yousef AL Saleh |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2022-12-01
|
Series: | Dubai Diabetes and Endocrinology Journal |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/527475 |
Similar Items
-
Evolving role of semaglutide in NAFLD: in combination, weekly and oral administration
by: Evgenia Koureta, et al.
Published: (2024-02-01) -
Survey of the knowledge and attitude of physicians toward the management of diabetes mellitus during Ramadan
by: Mohamed Hassanein, et al.
Published: (2016-09-01) -
Semaglutide for the treatment of obesity
by: Rafał Oleszczuk, et al.
Published: (2022-01-01) -
The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against Obesity: STEP or SURPASS?
by: Han Na Jung, et al.
Published: (2022-03-01) -
The Blessings of Ramadan /
by: Javed Ali
Published: (2002)